1. |
Jmoudiak M, Futerman AH. Gaucher disease:pathological mechanisms and modern management [J]. Br J Haematol, 2005; 129(2): 178-188.
|
2. |
施惠平, 张为民, 臧晏, 等. 中国10例戈谢病基因型与临床表型的相关性 [J]. 中华儿科杂志, 2001; 39(3): 131-133.
|
3. |
Stirnemann J, Caubel I, Kettaneh A, et al. Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease [J]. Presse Med, 2003; 32(11): 503-511.
|
4. |
李金, 汪海源, 邵华, 等. 戈谢病的研究进展 [J]. 国外医学儿科学分册, 2002; 29(5): 274-276.
|
5. |
张宗利, 高延超, 郑立杰. 成人型戈谢病2例 [J]. 中国实用外科杂志, 2008; 28(7): 599-600.
|
6. |
段彦龙, 张永红, 臧晏, 等. 酶替代治疗戈谢病72例 [J]. 中华儿科杂志, 2006; 44(9): 653-656.
|
7. |
Weinreb NJ, Charrow J, Andersson HC, et al. Effectiveness of enzyme replacement therapy in 1 028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry [J]. Am J Med, 2002; 113(2): 112-119.
|
8. |
Goldblatt J, Szer J, Fletcher JM, et al. Enzyme replacement therapy for Gaucher disease in Australia [J]. Intern Med J, 2005; 35(3): 156-161.
|
9. |
Rozé B, Lambert Y, Potard M, et al. Voluminous nodular splenomegaly in Gaucher disease: A case report [J]. Rev Med Interne, 2009; 30(10): 904-906.
|
10. |
Pastores GM, Barnett NL, Kolodny EH. An open-ladel, noncomparative study of miglustat in typeⅠGaucher disease: efficacy and tolerability over 24 months of treatment [J]. Clin Ther, 2005; 27(8): 1215-1227.
|